Comparison of Trial-Collected and Parent-Reported Race and Ethnicity in a Children’s Oncology Group Trial - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparing Race and Ethnicity Recorded in a Children’s Oncology Group Trial With Parent-Reported Information

  • By

  • Callie Fry

  • Eva Robinson

  • Edie Weller

  • Morgan A. Paul

  • Rahela Aziz-Bose

  • Leanne Duhaney

  • McKenzie Griffin

  • Kristine Karvonen

  • Colleen A. Kelly

  • Sunyu Kang

  • Haley Newman

  • Puja J. Umaretiya

  • Daniel J. Zheng

  • Sumit Gupta

  • Rachel E. Rau

  • David T. Teachey

  • Sarah Alexander

  • John A. Kairalla

  • Kira Bona

  • November 11, 2026

Share

Clinical Scorecard: Comparing Race and Ethnicity Recorded in a Children’s Oncology Group Trial With Parent-Reported Information

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Comparing Race and Ethnicity Recorded in a Children’s Oncology Group Trial With Parent-Reported Information
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPopulation described in the source article.
Care SettingA randomized phase III COG National Clinical Trials Network trial conducted at 217 sites in the United States and Canada; this analysis included US participants.

Key Highlights

  • Trial-collected race and ethnicity were missing for 8.7% of US participants, compared with 1.0% for parent-reported information.
  • Agreement with parent report was moderate for race (72.8%; κ = 0.45), substantial for ethnicity (83.0%; κ = 0.65), and substantial for the combined measure (78.6%; κ = 0.67).
  • The trial’s combined race and ethnicity classification differed from parent report for about 1 in 5 children.
  • Concordance was lowest for parent-reported multiracial participants: 11.6%; 47.8% were classified by the trial as non-Hispanic White.

Guideline-Based Recommendations

Diagnosis

  • The analysis used parent-reported race and ethnicity as the reference standard for assessing concordance with trial-collected data.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        US participants aged 1 to 9 years with newly diagnosed B-cell ALL enrolled in COG AALL1731; parents or guardians could complete the survey in English, Spanish, or French.

        This study evaluated race and ethnicity data collection, not treatment efficacy or prescribing. Parent-reported information was missing less often than trial-collected information.

        Clinical Best Practices

          Related Resources & Content

          Original Source(s)

          Related Content